Editorial: Diagnostic application of the A1c assay in renal disease

Journal of the American Society of Nephrology

Volumn 21, Issue 3, 2010, Pages 383-385

  Sharif, Adnan ^a   Baboola, Keshwar ^b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; COTRIMOXAZOLE; GANCICLOVIR; HEMOGLOBIN A1C; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; THYMOCYTE ANTIBODY; GLYCOSYLATED HEMOGLOBIN;

ANEMIA; BONE MARROW SUPPRESSION; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DRUG INHIBITION; EDITORIAL; GLUCOSE BLOOD LEVEL; GLYCATION; GRAFT RECIPIENT; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; UREMIA; METABOLISM;

ANEMIA; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY FAILURE, CHRONIC; UREMIA;

EID: 77949901669     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010010031     Document Type: Editorial

References (18)

1. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32: 1327-1334, 2009
2. Ansari A, Thomas S, Goldsmith D: Assessing glycemic control in patients with diabetes and end-stage renal failure. Am J Kidney Dis 41: 523-531, 2003 (Pubitemid 36278368)
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329: 977-986, 1993 (Pubitemid 23307905)
4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 837-853, 1998
5. Smith WG, Holden M, Benton M, Brown CB: Glycosylated and car-bamylated haemoglobin in uraemia. Nephrol Dial Transplant 4: 96-100, 1989
6. Coban E, Ozdogan M, Timuragaoglu A: Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol 112: 126-128, 2004 (Pubitemid 39274157)
7. Freedman D, Dandona P, Fernando O, Moorhead JF: Glycosylated haemoglobin in chronic renal failure and after renal transplantation. J Clin Pathol 35: 737-739, 1982 (Pubitemid 12092658)
8. De Marchi S, Cecchin E, Basile A, Donadon W, Lippi U, Quaia P, Tesio F: More on the increase of hemoglobin A1 in chronic renal failure: The role of acidosis. Nephron 35: 49-53, 1983 (Pubitemid 13069687)
9. Selvaraj N, Bobby Z, Sridhar MG: Increased glycation of hemoglobin in chronic renal failure: [Corrected] potential role of oxidative stress [published erratum appears in Arch Med Res 39: 466, 2008]. Arch Med Res 39: 277-284, 2008
10. Uzu T, Hatta T, Deji N, Izumiya T, Ueda H, Miyazawa I, Kanasaki M, Isshiki K, Nishio T, Arimura T: Target for glycemic control in type 2 diabetic patients on hemodialysis: Effects of anemia and erythro-poietin injection on hemoglobin A(1c). Ther Apher Dial 13: 89-94, 2009
11. Nevalainen P, Lahtela JT, Mustonen J, Pasternack A: The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients. Nephrol Dial Transplant 12: 145-150, 1997 (Pubitemid 27046218)
12. Davidson J, Wilkinson A, Dantal J, Dotta F, Haller H, Hernández D, Kasiske BL, Kiberd B, Krentz A, Legendre C, Marchetti P, Markell M, van der Woude FJ, Wheeler DC, International Expert Panel. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 75[Suppl]: SS3-S24, 2003
13. Winkelmayer WC, Chandraker A: Pottransplantation anemia: Management and rationale. Clin J Am Soc Nephrol 3[Suppl 2]: S49-S55, 2008
14. Vanrenterghem Y, Ponticelli C, Morales JM, Abramowicz D, Baboolal K, Eklund B, Kliem V, Legendre C, Morais Sarmento AL, Vincenti F: Prevalence and management of anemia in renal transplant recipients: A European survey. Am J Transplant 3: 835-845, 2003 (Pubitemid 36827905)
15. Arbeiter K, Greenbaum L, Balzar E, Muller T, Hofmeister F, Bidmon B, Aufricht C. Reproducible erythroid aplasia caused by mycophenolate mofetil. Pediatr Nephrol 14: 195-197, 2000 (Pubitemid 30122140)
16. Al-Uzri A, Yorgin PD, Kling PJ: Anemia in children after transplantation: Etiology and the effect of immunosuppressive therapy on eryth-ropoiesis. Pediatr Transplant 7: 253-264, 2003 (Pubitemid 36988279)
17. Augustine JJ, Knauss TC, Schulak JA, Bodziak KA, Siegel C, Hricik DE: Comparative effects of sirolimus and mycophenolate mofetil on erythro-poiesis in kidney transplant patients. Am J Transplant 4: 2001-2006, 2004
18. Jaster R, Bittorf T, Klinken SP, Brock J: Inhibition of proliferation but not erythroid differentiation of J2E cells by rapamycin. Biochem Pharmacol 51: 1181-1185, 1996 (Pubitemid 26130410)